CIK 0001728117
- Non-accelerated filer
- Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475461709
- Phone
- +1 858-684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2022-06-09 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-06-09 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Burow Kristina Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2019-06-10 | Burow Kristina Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2019-02-12 | Burow Kristina Director | Conversion | +3,682,539 | 3,682,539 | ||
| 2019-02-12 | Burow Kristina Director | Conversion | +345,419 | 4,027,958 | ||
| 2019-02-12 | Burow Kristina Director | Conversion | +3,682,539 | 3,682,539 | ||
| 2019-02-12 | Burow Kristina Director | Conversion | +345,419 | 4,027,958 | ||
| 2019-02-12 | Burow Kristina Director | Conversion · Series A Preferred Stock | −16,571,429 | 0 | ||
| 2019-02-12 | Burow Kristina Director | Conversion · Series A Preferred Stock | −16,571,428 | 0 | ||
| 2019-02-12 | Burow Kristina Director | Conversion · Series B Preferred Stock | −1,554,388 | 0 | ||
| 2019-02-12 | Burow Kristina Director | Conversion · Series B Preferred Stock | −1,554,388 | 0 |
Page 1 of 1 · 13 trades